A phase I clinical trial to test IL - 15 treatment in patients with pancreatic cancer began in 2012. (cancerresearch.org)
Different types of treatment are available for patients with pancreatic cancer. (cancer.gov)
That study showed how a similar model can be used to understand immune response in patients with pancreatic cancer who survive longer than others. (sciencedaily.com)